Arcturus Therapeutics Holdings Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ARCT

organization

SIC: 2834

SEC Insider

$149.1M

178 transactions

Summary

Arcturus Therapeutics Holdings Inc. (ARCT) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $808KSales: $138.5M17 insiders

Date	Insider	Type	Value
2025-08-15	SASSINE ANDY(Chief Financial Officer)	Buy	$21K
2025-08-15	SASSINE ANDY(Chief Financial Officer)	Buy	$21K
2026-06-05	Marantz Jing L.	A	$0
2026-06-05	Marquet Magda	A	$0
2026-06-05	Slaoui Moncef	A	$0
2026-06-05	Markels John	A	$0
2026-06-05	BARLOW JAMES F	A	$0
2026-06-05	FARRELL PETER C	A	$0
2026-06-05	HOLMES EDWARD W	A	$0
2026-05-01	MULROY DENNIS(Chief Financial Officer)	A	$0
2025-12-17	Kurata Lance(Chief Legal Officer)	A	$0
2025-12-17	Payne Joseph E(President and CEO)	A	$0
2025-12-17	Chivukula Pad(Chief Scientific Officer & COO)	A	$0
2025-12-17	Roberts Joseph(Controller)	A	$0
2025-06-09	HOLMES EDWARD W	A	$0
2025-06-09	BARLOW JAMES F	A	$0
2025-06-09	Marantz Jing L.	A	$0
2025-06-09	Markels John	A	$0
2025-06-09	Marquet Magda	A	$0
2025-06-09	Slaoui Moncef	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Arcturus Therapeutics Holdings Inc. — Contributions, Lobbying & Contracts | Poliscope